跳至主要内容
临床试验/NCT07130487
NCT07130487招募中不适用

Project CARE: CAncer Risk Evaluation (CARE)

Anita Y. Kinney, PhD, RN1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2025年11月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
210
试验地点
1
主要终点
Proportion of Patients Completing the Hereditary Cancer Risk Assessment

研究概览

简要总结

The purpose of Project CARE (cancer risk assessment and evaluation) research study is to explore the acceptance and feasibility of a study-initiated proactive outreach and digital care delivery model for conducting hereditary cancer risk assessment in primary care settings and facilitating genetic risk evaluation for patients flagged as high risk. Potential participants will be recruited from Rutgers Health primary care sites (family practice and general internal medicine). EPIC will be used to identify all potential participants and they will be invited to participate in the study. Consented participants will be provided a link via email, and or text message to engage with a Relational Agent (RA, chatbot), through the patient portal for cancer risk assessment and genetic education. Those identified as high risk will be offered genetic counseling and testing.

The research questions the study aims to answer are:

  1. What percent of patients who completed the RA are identified as high risk?
  2. What percent of patients who engaged with the risk assessment were identified as high risk?
  3. What percent of high-risk patients had genetic counseling or genetic testing within 4 months of completing the risk assessment?

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 18 to 70 years
  • •Able to read and speak English
  • •Have an email address or mobile phone number in EPIC and/or are enrolled in MyChart
  • •Receiving health care in Family Medicine or General Internal Medicine at Rutgers Health within the past 2 years
  • •Have not opted out of receiving research-related communications
  • •Have internet access (via smartphone, tablet, or computer)

排除标准

  • •Dementia (e.g., Alzheimer's disease) as indicated in EPIC
  • •Unable to access the Internet (via smartphone, tablet, or computer)
  • •Previous germline genetic testing for hereditary cancer risk
  • •Opted out of research participation in EPIC
  • •Have a personal history of cancer

研究组 & 干预措施

Feasibility and Acceptability of Relational Agent Chatbot

Experimental

干预措施: Relational Agent ( RA) Alex (Behavioral)

结局指标

主要结局

Proportion of Patients Completing the Hereditary Cancer Risk Assessment

时间窗: Up to 3 months from enrollment

The proportion of patients who successfully complete the hereditary cancer risk assessment within the genetic care delivery portal. Completion is defined as receiving a final result statement, regardless of whether all assessment questions in the risk assessment module were answered.

Proportion of Patients Identified as High Risk

时间窗: Through study completion, an average of 12 months.

The percent of patients who completed the RA and are identified as high risk.

次要结局

  • RA Engagement Rate(Up to 3 months from enrollment)
  • Retention Rate of High-risk Participants at 1-Month(1-month post high-risk identification)
  • Satisfaction with the Risk Assessment Feature of the Relational Agent(Through study completion, an average of 12 months.)

研究者

发起方
Anita Y. Kinney, PhD, RN
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Anita Y. Kinney, PhD, RN

Director at Rutgers Cancer Institute

Rutgers, The State University of New Jersey

研究点 (1)

Loading locations...

相似试验